D-0696-2021 Class II Terminated
FDA drug recall D-0696-2021 was initiated by API Solutions Inc. on July 15, 2021 and is designated Class II. Reason for recall: cGMP Deviations The recall status is terminated (terminated February 8, 2022). Affected quantity: 1 bottle.
Recall Details
- Product Type
- Drugs
- Report Date
- August 4, 2021
- Initiation Date
- July 15, 2021
- Termination Date
- February 8, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1 bottle
Product Description
Azelaic Acid 99.0+% Micro 500 Grams, Distributed By: A.P.I. Solutions Daphne Alabama Manufactured by: Yicheng Chemicals Corp. China Distributed by: Syntec Pharma Corp New York
Reason for Recall
cGMP Deviations
Distribution Pattern
AL, AZ, CO, FL, VA
Code Information
Lot #: AZA181105, Exp 11/09/2021